Different-Dose SCRT Plus CAPOX, PD-1 Blockade and IL-2 in LARC
Clinical trial NCT07646639 · RECRUITING
Trial details
- NCT number
- NCT07646639
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-20
- Primary completion
- 2028-12-31
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.